The presence of p53 protein mutations and changes in the number of H2A.X gene copies were found in breast cancer; changes in the H2A.X promoter were associated with a higher risk of breast cancer and non-Hodgkin′s lymphoma [38]. This evidence concerns the gene H2AX and non-Hodgkin lymphoma.